Cosmos Health Inc (COSM) Stock Analysis

Verdict: AVOID

Surging revenue and insider buys clash with acute cash burn, $15.98M debt, and NASDAQ delisting risk under $1.00.

Investment score: 35/100

Analysis as of

Is Cosmos Health Inc stock worth reviewing? The TradeMates thesis

TradeMates views Cosmos Health as a high-risk micro-cap where solid top-line growth is offset by persistent cash drain, low gross margins, and delisting overhang.

7-factor investment score

Cosmos Health Inc opportunities and risks

What speaks for COSM

What speaks against COSM

Frequently asked questions about Cosmos Health Inc (COSM)

Is COSM stock a good investment?

The TradeMates model rates Cosmos Health Inc as AVOID with an investment score of 35/100. TradeMates views Cosmos Health as a high-risk micro-cap where solid top-line growth is offset by persistent cash drain, low gross margins, and delisting overhang. This is algorithmic model output, not personal investment advice.

Is COSM stock a buy?

The TradeMates model verdict for COSM is AVOID with an investment score of 35/100. Treat this as a model signal to review, not a personal buy recommendation.